Lilly Sues Six Companies Over Illegal Retatrutide Sales

Retatrutide Black Market Lawsuits Target Six Compounding Pharmacies and Online Sellers Pharmaceutical analysts note that demand for weight-loss treatments has fueled a thriving ⁠online market for products claiming to contain weight-loss drugs. Illicit sellers frequently attempt to bypass federal oversight by labeling products as “research-use only.” Testing of seized black-market inventory reveals severe safety hazards, … Read more

Trump Ends Medicaid and CHIP Funding for Youth Gender Care

The Trump administration is implementing a federal rule that cuts off Medicaid and Children’s Health Insurance Program (CHIP) funding for gender-affirming care for minors, according to the Centers for Medicare and Medicaid Services (CMS). The policy change, which targets treatments like puberty blockers, hormones, and surgeries, is scheduled to take effect on Oct. 13. CMS … Read more

Cardinal Health Price Target Raised Following Strong Profit Guidance

Cardinal Health shares set a record close after the company reported fourth-quarter fiscal 2026 results that beat adjusted earnings expectations despite a top-line revenue miss, according to LSEG data. Revenue for the quarter ending June 30 increased nearly 6% year over year to $63.67 billion, falling short of the $65.03 billion consensus estimate, while adjusted … Read more

US Senate Confirms Mark Cruz to Lead Indian Health Service

The U.S. Senate confirmed Mark Cruz, a citizen of the Klamath Tribes, as the director of the Indian Health Service (IHS) in a 51-47 vote on Friday. Cruz will lead the federal agency responsible for healthcare delivery to approximately 2.8 million Native American and Alaska Native patients, filling a leadership vacancy that has persisted since … Read more

Procter & Gamble to Acquire Thorne for $3.8 Billion

Procter & Gamble has agreed to purchase supplement brand Thorne for $3.8 billion, marking a major expansion into the fast-growing wellness market as consumer demand for health-focused products surges. According to P&G CEO Shailesh Jejurikar, who spoke on CNBC’s “Squawk on the Street,” the acquisition is set to be announced Tuesday and represents a strategic … Read more

FDA Reviews Popular Peptides BPC-157 and TB-500 Amid RFK Jr. Backing

Health advisers convened by the Food and Drug Administration are reviewing more than a half-dozen peptides, unproven substances that have gained popularity in wellness trends despite limited safety and efficacy data. Kennedy Jr. FDA Panel Weighs Compounding Safety for Popular Peptides Federal regulators are evaluating whether to allow seven popular peptides to be added to … Read more

Johnson & Johnson (JNJ) Q2 Earnings Report: Key Takeaways

Johnson & Johnson surpassed Wall Street expectations for its second-quarter financial results, reporting $25.31 billion in total sales—a 6.6% increase year-over-year. Driven by strong demand for immunology drug Tremfya and oncology treatment Darzalex, the healthcare giant raised its full-year guidance, now projecting mid-point sales of $101.1 billion and adjusted earnings of $11.68 per share. Pharmaceutical … Read more

Patrick Dempsey Rules Out Maine Senate Run

Actor Patrick Dempsey announced Wednesday he will not run for the Maine Senate seat, ending rumors that he would replace Democratic nominee Graham Platner. Platner withdrew from the high-stakes race following sexual assault allegations from a former girlfriend, which the oyster farmer and Marine veteran denies. Why did the Maine Senate race undergo a sudden … Read more

Venezuela Quakes: Disease Risks and Hospital Crises Mount

Venezuela’s healthcare system is facing a critical collapse following two powerful earthquakes, with international aid groups warning that damaged infrastructure and understaffed facilities are struggling to manage a surge in trauma cases. According to the United Nations and the World Health Organization (WHO), at least 38 hospitals have been compromised, leaving thousands of displaced residents … Read more

Doctor Charged in $89M Fraud Scheme Targeting Student-Athletes

Federal prosecutors have charged Texas physician Jason Finkelstein with healthcare fraud and conspiracy, alleging he orchestrated an $89 million scheme that billed insurers for unnecessary cardiovascular screenings of college athletes. According to the U.S. Department of Justice, Finkelstein routinely certified test results as “normal” without reviewing them, leading to undetected cardiac issues in patients and … Read more